Randomized comparison of high-sensitivity troponin reporting in undifferentiated chest pain assessment

Circulation: Cardiovascular Quality and Outcomes

Volumn 9, Issue 5, 2016, Pages 542-553

  Chew, Derek P ^a,b   Zeitz, Christopher ^c,d   Worthley, Matthew ^c,d   Grantham, Hugh ^a   Beltrame, John ^c,e   Arstall, Margaret ^f   Coates, Penelope ^g   Astley, Carolyn ^a,h   Quinn, Stephen ^a   Ratcliffe, Julie ^a   Horsfall, Matthew ⁱ   Aylward, Philip G ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e QUEEN ELIZABETH HOSPITAL   (Australia)

^f Lyell McEwen Health Service   (Australia)

^g SA Pathology   (Australia)

^h Heart Foundation   (Australia)

ⁱ SA Health   (Australia)

Author keywords

acute coronary syndrome; angiography; clinical trial; myocardial infarction; troponin T

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN T; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HAZARD RATIO; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HIGH SENSITIVITY REPORTING; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; KAPLAN MEIER METHOD; LIMIT OF DETECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; ST SEGMENT ELEVATION; STANDARD REPORTING; THORAX PAIN; TREATMENT OUTCOME; ANGINA PECTORIS; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTOR; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; BIOMARKERS; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; TIME FACTORS; TROPONIN T;

EID: 84988498684     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.115.002488     Document Type: Article

References (28)

1. Chew DP, Aroney CN, Aylward PE, Kelly AM, White HD, Tideman PA, Waddell J, Azadi L, Wilson AJ, Ruta LA, 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ 2011 20 487 502
2. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ, ACC/AHA Task Force Members; Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 130 2354 2394. doi: 10.1161/CIR.0000000000000133
3. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol Ç Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GY, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Luis Zamorano J, 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016 37 267 315. doi: 10.1093/eurheartj/ehv320
4. Bandstein N, Ljung R, Johansson M, Holzmann MJ, Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014 63 2569 2578. doi: 10.1016/j.jacc.2014.03.017
5. Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD, Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999 354 1757 1762
6. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E, TACTICS-TIMI 18 Investigators Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001 286 2405 2412
7. Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Van De Werf F, Pfisterer M, Hasselblad V, Califf RM, Topol EJ, Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation 2001 103 2891 2896
8. Apple FS, Collinson PO, IFCC Task Force on Clinical Applications of Cardiac Biomarkers Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012 58 54 61. doi: 10.1373/clinchem.2011.165795
9. Apple FS, Wu AH, Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001 47 377 379
10. Apple FS, A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009 55 1303 1306. doi: 10.1373/clinchem.2009.128363
11. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C, Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009 361 858 867. doi: 10.1056/NEJMoa0900428
12. Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, Mohammed AA, Schlett CL, Nagurney JT, Hoffmann U, Koenig W, High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010 121 1227 1234. doi: 10.1161/CIRCULATIONAHA.109.893826
13. Diamond GA, Kaul S, How would the Reverend Bayes interpret high-sensitivity troponin? Circulation 2010 121 1172 1175. doi: 10.1161/CIR.0b013e3181d839e8
14. Astley CM, Beltrame JF, Zeitz C, Worthley M, Coates P, Murray A, Arstall M, Grantham H, Dunn R, Quinn S, Aylward PE, Chew DP, Study design of embracing high-sensitivity troponin effectively: the value of more information: a randomized comparison. Contemp Clin Trials 2014 39 183 190. doi: 10.1016/j.cct.2014.08.012
15. Aroney C, Aylward P, Kelly A, Chew D, Clune E, National Heart Foundation of Australia Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006 184 S1 S35
16. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB, Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006 333 1091. doi: 10.1136/bmj.38985.646481.55
17. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E, The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000 284 835 842
18. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR, Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons; Biomarker Subcommittee; ECG Subcommittee; Imaging Subcommittee; Classification Subcommittee; Intervention Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; ESC Committee for Practice Guidelines (CPG); Document Reviewers Third universal definition of myocardial infarction. J Am Coll Cardiol 2012 60 1581 1598. doi: 10.1016/j.jacc.2012.08.001
19. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011 123 2736 2747. doi: 10.1161/CIRCULATIONAHA.110.009449
20. Chew DP, Briffa TG, Alhammad NJ, Horsfall M, Zhou J, Lou PW, Coates P, Scott I, Brieger D, Quinn SJ, French J, High sensitivity-Troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: an examination against criteria of causality. Eur Heart J Acute Cardiovasc Care 2015 4 419 428. doi: 10.1177/2048872614564083
21. Mills NL, Churchhouse AM, Lee KK, Anand A, Gamble D, Shah AS, Paterson E, MacLeod M, Graham C, Walker S, Denvir MA, Fox KA, Newby DE, Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011 305 1210 1216. doi: 10.1001/jama.2011.338
22. Forel D, Technology Brief: High Sensitivity Troponin Assays for the Diagnosis of Myocardial Infarction (Version 1.0) 2012 Brisbane, Queensland Health Policy Advisory Committee on Technology Australia and New Zealand; 1 13
23. Recommendations for the Use of Troponin Assays for the Rapid Diagnosis of Acute Coronary Syndrome in the Emergency Department 2013 Canadian Agency for Drugs and Technologies in Health 1 10
24. Myocardial infarction (acute) Early Rule Out Using High-Sensitivity Troponin Tests (Elecsys Troponin T High-Sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 Assays): NICE Diagnostic Guidance (DG15) 2014 UK Diagnostic Advisory Committee NICE 1 53
25. Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, Aldous S, Meller B, Tate JR, Reichlin T, Hammett CJ, Zellweger C, Ungerer JP, Rubini Gimenez M, Troughton R, Murray K, Brown AF, Mueller M, George P, Mosimann T, Flaws DF, Reiter M, Lamanna A, Haaf P, Pemberton CJ, Richards AM, Chu K, Reid CM, Peacock WF, Jaffe AS, Florkowski C, Deely JM, Than M, Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013 62 1242 1249. doi: 10.1016/j.jacc.2013.02.078
26. Than M, Aldous S, Lord SJ, Goodacre S, Frampton CM, Troughton R, George P, Florkowski CM, Ardagh M, Smyth D, Jardine DL, Peacock WF, Young J, Hamilton G, Deely JM, Cullen L, Richards AM, A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med 2014 174 51 58. doi: 10.1001/jamainternmed.2013.11362
27. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, Moehring B, Ziller R, Hoeller R, Rubini Gimenez M, Haaf P, Potocki M, Wildi K, Balmelli C, Freese M, Stelzig C, Freidank H, Osswald S, Mueller C, One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012 172 1211 1218. doi: 10.1001/archinternmed.2012.3698
28. Body R, Carley S, McDowell G, Pemberton P, Burrows G, Cook G, Lewis PS, Smith A, Mackway-Jones K, The Manchester acute coronary syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation. Heart 2014 100 1462 1468. doi: 10.1136/heartjnl-2014-305564